Alternating weekly doxorubicin and 5‐fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A southwest oncology group study

Georgiana K. Ellis, Stephanie Green, Susan Schulman, Charles A. Coltman, Harry E. Hynes, Saul Rivkin, Robert B. Livingston

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Alternating weekly doxorubicin and 5‐fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A southwest oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences